Virtual Library

Start Your Search

Fatmir Spiro Caushi

Author of

  • +

    Lunch & Poster Display session (ID 58)

    • Event: ELCC 2019
    • Type: Poster Display session
    • Track:
    • Presentations: 1
    • Moderators:
    • Coordinates: 4/11/2019, 12:30 - 13:00, Hall 1
    • +

      78P - Lung resection for cancer in patients with heart disease: Management and postoperative outcome (ID 385)

      12:30 - 13:00  |  Presenting Author(s): Fatmir Spiro Caushi

      • Abstract
      • Slides


      Patients with lung cancer sometimes presents with concomitant heart disease. That kind of patients represents a high risk group necessitating prompt diagnosis and treatment. As lung resection still is the treatment of choice for early stages of lung cancer, its feasibility depends on the severity of the cardiac impairment. The aim of this study was to analyze the results of lung resection in patients with heart disease in terms of 30 day postoperative mortality, hospital stay and 5 year survival.

      a9ded1e5ce5d75814730bb4caaf49419 Methods

      This was a retrospective analysis of 161 patients with lung cancer who underwent complete lung resection between January 2011 and January 2014 at our department.

      20c51b5f4e9aeb5334c90ff072e6f928 Results

      Surgery consisted in 140 lobectomies, 21 pneumonectomies. 24,2% of patients (39) of this study had a cardiac disease as co-morbidity where 14 of them was suffering from hyper tension of second stage, 10 of them from chronic atrial fibrillation, 14 patients (8.7%) with coronary artery disease where 10 of them have been treated previously by CABG or PTCA revascularization procedure meanwhile in 4 patients the disease was diagnosed in routine examinations. One patient had undergone a cardiac surgery for mitral valve replacement. In both of 4 patients that were diagnosed with coronary disease was not required myocardial revascularization despite presented a medium-high cardiac risk and the surgery was performed under the continuous control of cardiologists. The mortality rate was 3%. There was one intraoperative death because of cardiac arrhythmia, and 4 deaths in first 30 days post operation (one of them because of heart attack in a pre-treated coronary disease by PTCA and 3 others by severe pneumonia). Hospital stay was longer for patients who had cardiac co-morbidity (12.3±4 vs. 8.5±3 days). The overall 5-year survival rate was 60%. In patients cardiopulmonary co-morbidity the 5-year survival rate was 40%.

      fd69c5cf902969e6fb71d043085ddee6 Conclusions

      Lung resection in patients with cardiac disease is feasible. Careful preoperative evaluation can identify patients who might benefit from myocardial revascularization prior to surgery. A careful cardiac treatment and follow-up of such patients its necessary to achieve better results regarding mortality and 5-year survival.

      b651e8a99c4375feb982b7c2cad376e9 Legal entity responsible for the study

      Fatmir Caushi.

      213f68309caaa4ccc14d5f99789640ad Funding

      Has not received any funding.

      682889d0a1d3b50267a69346a750433d Disclosure

      All authors have declared no conflicts of interest.


      Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.